Multidrug Resistance (MDR) is a type of resistance of tumor cells to various kinds of chemotherapeutic drugs which are structurally unrelated and also one of the major impediments to chemotherapeutic treatment of cancer. [1] [2] [3] [4] It has been reported that 49 ATP-binding cassette (ABC) transporter genes are present in the human genome. Among them, over-expression of P-glycoprotein (P-gp), encoded by MDR1 gene is one of the major factors contributing to multidrug resistance which leads to barrier to successful chemotherapy. 5, 6 Therefore the availability of safe and potent MDR reversal agents would be beneficial for clinical use. Reversal agents can act by binding to the membrane transport protein (P-gp), by inhibiting MDR's drug efflux capacity, or by suppressing expression of the MDR1 gene itself.
7 Although a number of P-gp inhibitors have been developed, there is currently no clinically useful drug that inhibits P-gp. In an attempt to find new and more effective MDR reversal agents, we previously identified adamantyl derivatives exhibiting more potent MDR reversal activity than verapamil, a well-known P-gp inhibitor, without considerable intrinsic cytotoxicity. Compounds 1-2 were identified utilizing high throughput image-based DIOC 2 efflux assays and anti-proliferation assays in a P-gp over-expressing MDR sarcoma cell line, MES-SA/DX5. Herein we describe a further structure-activity relationship study to find additional compounds in this series.
8,9
With the objective of investigating the effect of aminebased substituents on reversal activity, we synthesized a series of adamantyl derivatives 2a-t that feature reductive amination of the adamantyl aldehyde derivatives as a key step. The synthetic procedures for 2a-t are described in Schemes 1 to 3.
Synthesis of a new series of adamantyl derivatives (2a-t) were carried out starting from commercially available 3-amino benzoic acid 3 (Scheme 1). The corresponding esters (4a-d) and amides (4e-g) of 3-amino benzoic acid were prepared in the next step. Further alkylation with chloroacetyl chloride resulted in the alkylated derivatives (5a-g). Bromination of 1-adamantane carboxylic acid 6 with bromine gave an intermediate 7, which was followed by Friedel-Crafts alkylation with anisole to provide compound 8, as shown in Scheme 2. Esterification of 8 resulted in compound 9, which was reacted with LiAlH 4 to give an alcohol 10. The aldehyde 11 was then obtained by oxidation of alcohol 10. Demethylation of 11 was carried out by using BBr 3 to afford a phenol compound 12, which was utilized as a key intermediate to prepare the final compounds. Adamantyl aldehyde 13, a precursor for the synthesis of the target adamantyl motifs (2a-n), was generated by reacting 12 with methyl 3-(2-chloroacetamido) benzoate 5a. In similar fashion, the precursor 14o-t was generated by reacting 12 with 5b-g for the synthesis of derivatives 2o-t. Finally the reductive amination reaction of 13 or 14o-t with a variety of amine resulted in Pgp related MDR modulators 2a-t.
Reversal activity of these derivatives was evaluated in a These authors contributed equally to this work. 
Notes
MES-SA/DX5 cells. EC 50 values of the synthesized compounds were measured in the presence of 100 nM taxol. Some of these derivatives showed more potent MDR reversal activity than the well-known P-gp inhibitor, verapamil. Compound 2n with a pyrrolidinyl ethyl amino moiety displayed an EC 50 value of 0.66 µM, which is 13.5 fold more potent than verapamil (EC 50 = 0.66 vs 8.94 µM, respectively) as shown in Table 1 . Most alkyl amine derivatives were slightly more potent than verapamil. However, aniline analogues (2i, 2l and 2m) resulted in a marked loss of activity. Compound 2m bearing an electron withdrawing group showed complete loss of reversal activity. Reversal activity of morpholine derivatives (2f-h) is prone to decrease with increasing chain length. A further SAR study has been carried out with the synthesis of adamantyl derivatives 2o-t, keeping R 3 constant and introducing several substituents at either R 1 or R 2 . Unfortunately, none of the derivatives have better IC 50 values compared to 2n. Interestingly, a cyclopropyl amino compound (2t) was found to be over 9 fold more potent than verapamil, while replacement of the ester group with an amide (2r and 2s) led to no measurable activity. These results suggest that moderate hydrophobicity, size of the side chain and an amine with a proton seem to be essential to retain reversal activity. In summary, we identified potent MDR-reversing adamantyl compounds through a structure-activity relationship study. Compound 2n showed excellent reversal activity, which was about 13-fold more potent than verapamil. Further investigation may lead to the developments of clinically valuable MDR modulators.
Experimental Section
General Procedure for Reductive Amination Reaction (2a-t). To a stirred solution of the adamantyl aldehyde (13 for 2a-n, and 14o-t for 2o-t, respectively) (1 equiv), and amines (3.0 equiv) in methanol (10 volumes) at room temperature was added a solution of sodium cyanoborohydride (1 M) (1 equiv) and zinc chloride (0.5 M) (1 equiv) in methanol (5 mL). The resulting solution was stirred at room temperature for 8 hours. After most of the methanol was removed by evaporation under reduced pressure, the residue was purified by column chromatography to obtain the product (2a-t). The spectral data can be found in the supporting information.
